Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Hanny Al-Samkari
Person

Hanny Al-Samkari

Tracked across 1 events · 8 articles · First seen Aug 11, 2026 · Last active Aug 11, 2026

Sentiment
55
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 55
Business
Vaderis $152M Series B and Phase 3 HEROIC
Vaderis Therapeutics, a clinical-stage biopharmaceutical company focused on rare vascular diseases, announced the closing of an oversubscribed $152 million Series B financing and the initiation of its global Phase 3 HEROIC study. The financing was…
Impact: Principal Investigator of the HEROIC study, lending clinical credibility to the trial. His involvement is important for trial execution.
Aug 11, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Hanny Al-Samkari live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.